Cementless Total Knee Arthroplasty Market Expected to Reach $3 Billion by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “cementless total knee arthroplasty Market," The cementless total knee arthroplasty market size was valued at $1.9 billion in 2022, and is estimated to reach $3 billion by 2032, growing at a CAGR of 4.6% from 2023 to 2032. Cementless implants are press-fitted into the bone, as they have a special porous surface to stimulate bone growth. Bone growth happens over a long period; thus, not providing immediate fixation. Cementless knee arthroplasty approach is beneficial because it promotes better long-term stability and bone growth around the artificial joint, thereby leading to a more durable and successful outcome. 

Cementless implant fixation in knee arthroplasty offers a number of conceptual benefits including improved component fixation through direct osseointegration with the implant coatings, better preservation of the native bone stock, improved surgical efficiency and reduced systemic complications associated with cement impaction and debris wear.   

The growth of the cementless total knee arthroplasty market share is majorly driven by technological advancement in implant designs, materials, and surgical techniques, increasing obesity rates as obese people are more likely to have knee joint disorders such osteoarthritis and increased awareness campaigns about knee joint diseases, treatment options, and the benefits of cementless knee arthroplasty. For instance, in November 2022, Zimmer Biomet Holdings, Inc. announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for the Persona OsseoTi Keel Tibia for cementless knee replacement. Persona OsseoTi is the latest addition to the clinically proven Persona Knee System and features a new porous version of the Persona anatomic tibia with Zimmer Biomet's OsseoTi Porous Metal Technology.  

Moreover, the surge in the geriatric population and the increase in prevalence of osteoarthritis and rheumatoid arthritis among the geriatric population have led to an increase in demand for technologically advanced cementless knee implants and are the factors that propel the growth of the market. Furthermore, the surge in investments in R&D activities by pharmaceutical medical device manufacturers companies for the development of technologically advanced knee implants boosts the growth of the cementless total knee arthroplasty market.    

However, lack of awareness among patients and healthcare professionals about the benefits and availability of cementless knee arthroplasty and surgical complexity with cementless knee arthroplasty are the major factors that restrain the growth of the market. On the contrary, increase in number of sports tournaments conducted globally is expected to increase the risk of knee injury. This is of the major factor that increases the demand for knee arthroplasty and is expected to offer remunerative opportunities for the expansion of the global cementless total knee arthroplasty market in the future.  

On the basis of products, the cementless total knee arthroplasty market analysis is segmented into mobile bearings and fixed bearings, the fixed bearings segment generated maximum revenue in 2022, owing to various benefits offered by fixed-bearing platform such as it used as a standard for many cementless total knee arthroplasty (TKA) implants because of its simple design and low cost compared with mobile-bearing/rotating-platform implants.

However, the mobile bearings segment is expected to witness a significant CAGR during the forecast period, owing to advantages offered by mobile bearings such as improved clinical outcomes as compared to fixed-bearings, increased implant stability and enhanced longevity of prosthesis.  

On the basis of material, the alloys segment generated maximum revenue in 2022, owing to technological advancement in cementless knee implants, rise in awareness among people regarding the availability of alloy based cementless knee implants and the various benefits offered by alloys such as biocompatibility with human tissue, improved implant fixation and excellent wear resistance.

However, the others segment is expected to witness a significant CAGR during the forecast period, owing to the radiolucent properties of some plastics and advances in surgical techniques, such as the development of minimally invasive procedures, could complement the use of plastic-based cementless knee implants.   

On the basis of end user, the hospitals segment dominated the market in 2022, owing to rise in the prevalence of knee osteoarthritis, increase in the number of knee arthroplasty procedures conducted globally and availability of specialized surgeons in hospitals who are experts in cementless TKA.

The others segment is expected to witness the highest CAGR during the forecast period, owing to an increase in the patient preference for outpatients' surgeries at ambulatory surgical centers and orthopedic clinics and availability of technologically advanced medical devices at orthopedic centers and ambulatory surgical centers. 

On the basis of region, North America generated maximum revenue in 2022 owing to publicly funded healthcare systems, where the government Medicare covers the majority of the cost of medical treatment, surgeries, and orthopedic implants. In addition, the total number of patients undergoing total knee arthroplasty is relatively high in the developed countries such as the U.S. and Canada compared with other countries in the region. The increased awareness about implant surgeries among healthcare professionals and patients and the greater penetration of advanced medical facilities support the market growth in these countries.  

However, Asia-Pacific is expected to witness growth at the highest rate during the cementless total knee arthroplasty market forecast owing to highly populated countries along with a high prevalence of road accidents and osteoarthritis. In addition, the increasing number of sports tournaments increases the rate of sports-related injuries, that surges the demand for cementless knee arthroplasty implants, which provide lucrative opportunities for market growth. 

The major players profiled in the cementless total knee arthroplasty industry are Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Stryker Corporation, Johnson & Johnson, B. Braun Melsungen AG, Microport Scientific Corporation, Olympus Corporation (Group FH Ortho), Waldemar Link GmbH & Co. KG, United Orthopedic Corporation and X. NOV. 

Key findings of the study 

• On the basis of product, the fixed bearings held the largest share in the cementless total knee arthroplasty market in 2022. 

• On the basis of material, the alloys segment was the highest contributor to the cementless total knee arthroplasty industry in 2022.  

• On the basis of end user, the hospitals segment dominated the market in 2022 and are expected to remain dominant during the cementless total knee arthroplasty market forecast period.  

• On the basis of region, North America garnered the largest cementless total knee arthroplasty market trends. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period.